Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 12919, 9 pages
http://dx.doi.org/10.1155/MI/2006/12919
Research Communication

Tubulointerstitial Macrophage Accumulation is Regulated by Sequentially Expressed Osteopontin and Macrophage Colony-Stimulating Factor: Implication for the Role of Atorvastatin

Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China

Received 26 September 2005; Accepted 3 November 2005

Copyright © 2006 Shaojiang Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A A Eddy, “Progression in chronic kidney disease,” Advances in Chronic Kidney Disease, vol. 12, no. 4, pp. 353–365, 2005. View at Publisher · View at Google Scholar · View at PubMed
  2. A Schwarz, M Mengel, W Gwinner et al., “Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study,” Kidney International, vol. 67, no. 1, pp. 341–348, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. H J Anders, E Belemezova, V Eis et al., “Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice,” Journal of the American Society of Nephrology: JASN, vol. 15, no. 6, pp. 1504–1513, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. Q Wu, K Jinde, M Endoh, and H Sakai, “Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy,” Kidney International, vol. 65, no. 3, pp. 888–896, 2004. View at Publisher · View at Google Scholar · View at PubMed
  5. B A Young, E A Burdmann, R J Johnson et al., “Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity,” Kidney International, vol. 48, no. 2, pp. 439–448, 1995. View at Google Scholar · View at PubMed
  6. H Y Lan, D J Nikolic-Paterson, W Mu, and R C Atkins, “Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis,” Kidney International, vol. 48, no. 3, pp. 753–760, 1995. View at Google Scholar · View at PubMed
  7. U Panzer, F Thaiss, G Zahner et al., “Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis,” Kidney International, vol. 59, no. 5, pp. 1762–1769, 2001. View at Publisher · View at Google Scholar · View at PubMed
  8. N M Isbel, P A Hill, R Foti et al., “Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation,” Kidney International, vol. 60, no. 2, pp. 614–625, 2001. View at Publisher · View at Google Scholar · View at PubMed
  9. N M Isbel, D J Nikolic-Paterson, P A Hill, J Dowling, and R C Atkins, “Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 16, no. 8, pp. 1638–1647, 2001. View at Publisher · View at Google Scholar · View at PubMed
  10. V Ophascharoensuk, C M Giachelli, K Gordon et al., “Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis,” Kidney International, vol. 56, no. 2, pp. 571–580, 1999. View at Publisher · View at Google Scholar · View at PubMed
  11. Y Le Meur, G H Tesch, P A Hill et al., “Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway,” Journal of Leukocyte Biology, vol. 72, no. 3, pp. 530–537, 2002. View at Google Scholar · View at PubMed
  12. S Klahr and J J Morrissey, “Obstructive nephropathy and renal fibrosis,” American Journal of Physiology—Renal Physiology, vol. 283, no. 5, pp. F861–F875, 2002. View at Google Scholar · View at PubMed
  13. Z A Massy and C Guijarro, “Statins: effects beyond cholesterol lowering,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1738–1741, 2001. View at Publisher · View at Google Scholar · View at PubMed
  14. Y Mizuguchi, A Miyajima, T Kosaka, T Asano, T Asano, and M Hayakawa, “Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction,” The Journal of Urology, vol. 172, no. 6 pt 1, pp. 2456–2459, 2004. View at Publisher · View at Google Scholar · View at PubMed
  15. K L Edgtton, R M Gow, D J Kelly, P Carmeliet, and A R Kitching, “Plasmin is not protective in experimental renal interstitial fibrosis,” Kidney International, vol. 66, no. 1, pp. 68–76, 2004. View at Publisher · View at Google Scholar · View at PubMed
  16. S Mizuno, K Matsumoto, and T Nakamura, “Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy,” Kidney International, vol. 59, no. 4, pp. 1304–1314, 2001. View at Publisher · View at Google Scholar · View at PubMed
  17. Y Isaka, M Tsujie, Y Ando et al., “Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction,” Kidney International, vol. 58, no. 5, pp. 1885–1892, 2000. View at Publisher · View at Google Scholar · View at PubMed
  18. Y Xie, M Sakatsume, S Nishi, I Narita, M Arakawa, and F Gejyo, “Expression, roles, receptors, and regulation of osteopontin in the kidney,” Kidney International, vol. 60, no. 5, pp. 1645–1657, 2001. View at Publisher · View at Google Scholar · View at PubMed
  19. V P Persy, A Verhulst, D K Ysebaert, K E De Greef, and M E De Broe, “Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice,” Kidney International, vol. 63, no. 2, pp. 543–553, 2003. View at Publisher · View at Google Scholar · View at PubMed
  20. D M Lenda, E Kikawada, E R Stanley, and V R Kelley, “Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation,” The Journal of Immunology, vol. 170, no. 6, pp. 3254–3262, 2003. View at Google Scholar · View at PubMed
  21. S Lavaud, B Poirier, C Mandet et al., “Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats,” American Journal of Physiology—Renal Physiology, vol. 280, no. 4, pp. F683–F694, 2001. View at Google Scholar · View at PubMed
  22. B Lange-Sperandio, M S Forbes, B Thornhill, M D Okusa, J Linden, and R L Chevalier, “A(2A) adenosine receptor agonist and PDE(4) inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy,” Nephron. Experimental Nephrology, vol. 100, no. 3, pp. e113–e123, 2005. View at Publisher · View at Google Scholar · View at PubMed
  23. V Vielhauer, E Berning, V Eis et al., “CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome,” Kidney International, vol. 66, no. 6, pp. 2264–2278, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. J M Jr Vieira, E Mantovani, L T Rodrigues et al., “Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction,” Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1582–1591, 2005. View at Publisher · View at Google Scholar · View at PubMed
  25. C V Jr Serrano, V M Yoshida, M L Venturinelli et al., “Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia,” Atherosclerosis, vol. 157, no. 2, pp. 505–512, 2001. View at Publisher · View at Google Scholar · View at PubMed
  26. J K Park, D N Muller, E M Mervaala et al., “Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-and cholesterol-lowering effects,” Kidney International, vol. 58, no. 4, pp. 1420–1430, 2000. View at Publisher · View at Google Scholar · View at PubMed
  27. E N Wardle, “Nuclear factor κB for the nephrologist,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1764–1768, 2001. View at Publisher · View at Google Scholar · View at PubMed
  28. J J Morrissey and S Klahr, “Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis,” American Journal of Physiology—Renal Physiology, vol. 276, no. 1 pt 2, pp. F39–F45, 1999. View at Google Scholar · View at PubMed